Background: The T-piece resuscitator (TPR) is in common use worldwide to deliver positive pressure ventilation during resuscitation of infants <10 kg. Ease of use, ability to provide positive endexpiratory pressure (PEEP), availability of devices inbuilt into resuscitaires and cheaper disposable options have increased its popularity as a first-line device for term infant resuscitation. Research into its ventilation performance is limited to preterm infant and animal studies. Efficacy of providing PEEP and the use of TPR during term infant resuscitation are not established.
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Method: A single operator experienced in newborn resuscitation provided positive pressure ventilation in a randomised sequence to three different Crs models (0.5, 1 and 3 mL/cmH2O) at three different set PIP (20, 30 and 40 cmH2O). Set PEEP (5 cmH2O), gas flow rate and inflation rate were the same for each sequence.
Results: A total of 1087 inflations were analysed. The delivered mean PEEP was Crs dependent across set PIP range, rising from 4.9 to 8.2 cmH2O. At set PIP 40 cmH2O and Crs 3 mL/cmH2O, the delivered mean PIP was significantly lower at 35.3 cmH2O.
Conclusions: As Crs increases, the Neopuff TPR can produce clinically significant levels of auto-PEEP and thus may not be optimal for the resuscitation of term infants with healthy lungs. Background: Progesterone (PROG) therapy in pregnancy is used to reduce the risk of preterm labour however the effects on the steroid profile of the fetus remain unclear. We have previously found PROG therapy in male preterm guinea pig neonates leads to increased cortisol and reduced myelination. Hence, we aimed to determine the effects of PROG treatment on steroid profiles and neurodevelopmental markers in guinea pig fetuses.
PROGESTERONE THERAPY DURING PREGNANCY INCREASES MATERNAL BUT NOT FETAL CORTISOL OR NEUROSTEROID CONCENTRATIONS IN GUINEA PIGS
Method: Pregnant guinea pig dams were administered PROG or vehicle orally (GA29-61) and saliva collected daily. Fetal brains and plasma were collected at GA62 (preterm) and GA69 (term). We measured salivary PROG and plasma cortisol by EIA and the neurosteroid, allopregnanolone (ALLO), by RIA. The myelination marker, myelin basic protein (MBP) and astrocyte marker, glial fibrillary acidic protein (GFAP), were quantified by immunohistochemistry.
Results: PROG treatment significantly increased both maternal salivary PROG and cortisol levels. Plasma ALLO levels were unchanged. Term female fetuses exhibited raised PROG levels whilst both cortisol and ALLO levels remained unaffected. Fetal MBP and GFAP expression were also largely unaffected with only preterm males displaying reduced GFAP expression in the hippocampal CA1.
Conclusions: The placental barrier adequately protected the fetus from increased maternal cortisol following maternal PROG administration, however the treatment was not sufficient to raise ALLO levels. Method: Data was retrospectively collected on neonates born over two-years from TNH (n = 267) and MHW (n = 391). Neonates were aged between 32-36 weeks gestation (GA), weighed >1500 g at birth (BW), were seizure free and required no respiratory support.
DOES THE HOSPITAL ENVIRONMENT INFLUENCE TEST
Results: TNH's mean GA (34.69 AE 0.99 weeks) and BW (2303.79 AE 442.64 g) were similar to MHW's (GA 34.67 AE 1.24 weeks and BW 2294.50 AE 461.32 g): p = 0.80 and p = 0.82 respectively. TNH's outcomes did not differ significantly from MHW's (mean AE standard error lengths of stay of 11.6 AE 0.41 vs 11.6 AE 0.40 respectively, p = 0.44). TNH's mean (AE standard error) testordering rate of 1.11 AE 0.06 tests/patient/day was significantly lower than MHW's rate of 1.40 AE 0.07 tests/patient/day (p < 0.01). On average TNH ordered significantly fewer tests than MHW on days 1 and 2 of admission (2.54 AE 0.17 vs 3.62 AE 0.13, p < 0.01 and 1.63 AE 0.11 vs 2.17 AE 0.12, p < 0.01 respectively). Patterns of test types ordered and rates of tests requiring recollection differed between the hospitals.
Conclusions: Despite having demographically similar cohorts, significant differences in premature neonate test-ordering practices exist between TNH and MHW. Further investigation is warranted given potential patient and financial consequences. 
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